U.S. market Closed. Opens in 17 hours 4 minutes

RLMD | Relmada Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312019-06-302018-06-302017-06-302016-06-302015-06-302013-08-312012-08-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A5.13K7.94K
Cost of RevenueN/AN/A1.26K3.75KN/A4.87KN/AN/AN/AN/A4.04K5.80K
Gross ProfitN/AN/A-1.26K-3.75KN/A-4.87KN/AN/AN/AN/A1.09K2.14K
Operating Expenses103.70M161.25M125.70M60.84M15.11M12.73M6.92M7.22M16.22M17.10M46.11K13.82K
Selling, General & Admin48.89M47.93M35.08M24.87M7.25M5.70M3.97M5.93M10.01M9.23M46.11K13.82K
Research & Development54.81M113.32M90.62M35.97M7.86M7.02M2.94M1.29M6.21M7.87MN/AN/A
Other Operating ExpensesN/A6.35MN/AN/AN/AN/A2.35K216.21KN/AN/AN/AN/A
Operating Income-103.70M-161.25M-125.70M-60.84M-15.11M-12.73M-6.92M-7.22M-16.22M-17.10M-45.02K-11.68K
Other Expenses / Income4.91M1.55M-1.25M-16.95K104.11K-3.83M-706.55K932.86K13.24M-3.70MN/A-377.00
Before Tax Income-98.79M-157.04M-125.75M-59.46M-15.01M-17.32M-8.96M-6.29M-2.97M-20.80M-45.02K-12.05K
Income Tax Expenses-103.70K-2.66M48.32K-1.38M-1.004.59M2.05MN/AN/AN/AN/AN/A
Net Income-98.79M-157.04M-125.75M-59.46M-15.01M-17.32M-8.96M-6.29M-2.97M-20.80M-45.02K-12.05K
Interest ExpensesN/AN/AN/AN/AN/AN/A1.34MN/AN/A4.92KN/AN/A
Basic Shares Outstanding30.10M29.63M17.55M15.59M9.23M6.31M3.14M3.02M2.90M2.49M1.22M815.57K
Diluted Shares Outstanding30.10M29.63M17.55M15.59M9.23M6.31M3.14M3.02M2.90M2.49M1.22M815.57K
EBITDA-103.70M-156.44M-124.45M-60.82M-15.10M-8.89M-6.21M-6.20M-29.27M-17.08M-44.77K-12.05K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-872.78%-151.77%
EBIT-98.90M-159.70M-125.70M-60.84M-15.01M-12.73M-5.58M-6.29M-2.97M-20.80M-45.02K-12.05K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-877.66%-151.77%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312019-06-302018-06-302017-06-302016-06-302015-06-302013-08-312012-08-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙